41. A hybrid approach to achieving both marginal and conditional balances for stratification variables in sequential clinical trials. (30th July 2013) Authors: Lin, Yunzhi; Su, Zheng Journal: Pharmaceutical statistics Issue: Volume 12:Number 5(2013:Sep./Oct.) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. A meta‐analytic framework to adjust for bias in external control studies. (4th October 2022) Authors: Incerti, Devin; Bretscher, Michael T.; Lin, Ray; Harbron, Chris Journal: Pharmaceutical statistics Issue: Volume 22:Number 1(2023) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. A method for sample size calculation via E‐value in the planning of observational studies. (20th August 2020) Authors: Fang, Yixin; He, Weili; Hu, Xiaofei; Wang, Hongwei Journal: Pharmaceutical statistics Issue: Volume 20:Number 1(2021) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. A mixed effects model for analyzing area under the curve of longitudinally measured biomarkers with missing data. (20th June 2021) Authors: Shi, Luoxi; Hatsukami, Dorothy K.; Koopmeiners, Joseph S.; Le, Chap T.; Benowitz, Neal L.; Donny, Eric C.; Luo, Xianghua Journal: Pharmaceutical statistics Issue: Volume 20:Number 6(2021) Page Start: 1249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. A mixture model using likelihood‐based and Bayesian approaches for identifying responders and non‐responders in longitudinal clinical trials. (2nd September 2014) Authors: He, Jiwei; Entsuah, Richard Journal: Pharmaceutical statistics Issue: Volume 13:Number 5(2014:Sep./Oct.) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. A model selection criterion for clustered survival analysis with informative cluster size. (23rd August 2022) Authors: Chien, Li‐Chu; Chang, Li‐Ying; Shen, Chung‐Wei Journal: Pharmaceutical statistics Issue: Volume 22:Number 1(2023) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. A modified varying‐stage adaptive phase II/III clinical trial design. (5th June 2016) Authors: Dong, Gaohong; Vandemeulebroecke, Marc Other Names: Kieser Meinhard guestEditor. Journal: Pharmaceutical statistics Issue: Volume 15:Number 4(2016) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. A multistage analysis strategy for a clinical trial to assess successively more stringent criteria for a primary endpoint with a low event rate. (19th February 2013) Authors: Li, Siying; Hussey, Michael A.; Schwartz, Todd A.; Koch, Gary G. Journal: Pharmaceutical statistics Issue: Volume 12:Number 2(2013:Mar./Apr.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. A natural lead‐in approach to response‐adaptive allocation for continuous outcomes. (22nd January 2021) Authors: Donahue, Erin; Sabo, Roy T. Journal: Pharmaceutical statistics Issue: Volume 20:Number 3(2021) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. A note from the editors. (12th July 2022) Authors: Senn, Stephen; Smith, Mike K. Other Names: Senn Stephen guestEditor.; Smith Mike K. guestEditor. Journal: Pharmaceutical statistics Issue: Volume 21:Number 4(2022) Page Start: 700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗